Dose-escalation decisions in both phases are evaluated by a Safety Review Committee (SRC) , which assesses clinical, pharmacokinetic and safety data according to predefined stopping rules established in the study protocol
Results May Vary Individual results will vary based on factors including age, baseline weight, metabolic health, consistency of medication use, lifestyle factors (diet, physical activity, sleep), genetic factors, current medications, and other individual variables
Make an Appointment We proudly support men and women looking for meaningful weight loss solutions in Milwaukee, Waukesha, Germantown or anywhere in the greater Milwaukee area
New patients can begin semaglutide injection therapy at $189/mo (or $149/mo on the 6-month plan) on a flexible commitment schedule, with no insurance requirement and HSA/FSA eligibility
We imagine Cymbiotika being a lifestyle
MOTS-c Strength: 10 mg Mitochondrial-derived peptide A performance and energy-oriented peptide option frequently associated with metabolic resilience support